Maya Matthews
Head of Unit · EU
Meetings on record (latest 20 of 25)
- 2026-09-16 · European Patients' Forum (EPF) · Evaluation of the EU HTA Regulation, with a focus on patient involvement
- 2026-09-10 · European Federation of Pharmaceutical Industries and Associations · Exchange of views on implementation of the HTA Regulation
- 2026-07-08 · Genmab A/S · Exchange of views on the Biotech Act proposal adopted on 16 December 2025 and the Health Technology Assessment Regulation
- 2026-07-02 · European Confederation of Pharmaceutical Entrepreneurs · Exchange of views on implementation of the HTA Regulation
- 2026-07-02 · European Federation of Pharmaceutical Industries and Associations · Exchange of views on implementation of the HTA Regulation
- 2026-06-30 · European Association of Urology · Discussion of the EAU's current activities and links with the implementation of the Health Technology Assessment Regulation (HTAR).
- 2026-05-21 · Ghent University · Discussion on the findings of the expert Delphi study conducted on EU HTA PICO consolidation
- 2026-05-06 · European Confederation of Pharmaceutical Entrepreneurs · Exchange of views on reaching out to Small and Medium Enterprises (SMEs) under the Health Technology Assessment (HTA) Regulation
- 2026-03-11 · European Patients' Forum (EPF) · Discussion of the EPF's current activities and planned actions with respect to the implementation of the Health Technology Assessment Regulation (HTAR).
- 2026-02-11 · European Federation of Pharmaceutical Industries and Associations · Exchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs)
- 2026-02-11 · European Confederation of Pharmaceutical Entrepreneurs · Exchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs)
- 2025-11-24 · European Patients' Forum (EPF) · Discussion on EPF’s current activities and planned actions with respect to the Health Technology Assessment Regulation (HTAR) implementation
- 2025-11-06 · European Organisation for Research and Treatment of Cancer · Involvement of clinical experts taking part in joint clinical assessments and scientific consultations under the EU Health Technology Assessment (HTA) Regulation
- 2025-10-22 · European Confederation of Pharmaceutical Entrepreneurs · Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.
- 2025-10-22 · European Federation of Pharmaceutical Industries and Associations · Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.
- 2025-10-07 · International Society for Pharmacoeconomics and Outcomes Research · Discussion and exchange of views on the application of the Health Technology Assessment Regulation and the international health policy framework
- 2025-09-29 · EUROPEAN ORGANISATION FOR RARE DISEASES · Involvement of individual experts, including patients, taking part in joint clinical assessments and scientific consultations under the EU HTA Regulation, as well as capacity-building activities funded by the EU4Health
- 2025-09-23 · Ultragenyx Europe Gmbh · Understanding the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment
- 2025-07-25 · Università Cattolica del Sacro Cuore · Introduction to the EDiHTA project
- 2025-07-24 · European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry · Discuss the input received during the public feedback on the draft Implementing Regulation on joint clinical assessments for medical devices and in vitro diagnostic medical devices
Source: published meeting logs. Listing a meeting does not imply any wrongdoing.